Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanbi Antong prescription granules
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Administration
- Oral
01
Overview
Xuanbi Antong prescription granules is a Traditional Chinese Medicine (TCM) formulation developed by Guang’anmen Hospital of the China Academy of Chinese Medical Sciences (CACMS). It is indicated for the treatment of coronary artery disease (CAD), specifically for patients presenting with the "phlegm-stasis-heat interjunction" syndrome. The formulation is designed to address coronary stenosis (50-70%), alleviate angina symptoms, and improve electrocardiogram (ECG) outcomes. As a complex herbal mixture, its therapeutic approach involves multi-target effects such as resolving phlegm, removing blood stasis, and clearing heat to stabilize atherosclerotic plaques and improve myocardial perfusion. It is currently undergoing Phase 3 clinical evaluation in China.
- Other names
- Xuanbi Antong prescription granulesXuanbi Antong formulaXuanbi Antong granulesXuanbi Antong prescription
Beyond the preview
Go deeper on Xuanbi Antong prescription granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuanbi Antong prescription granules.